Browsing NTNU Open by Author "Kamyshna, Iryna"
Now showing items 1-4 of 4
-
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword
Petakh, Pavlo; Kamyshna, Iryna; Nykyforuk, Andriy; Yao, Rouan; Imbery, John Franklin; Oksenych, Valentyn; Korda, Mykhaylo; Kamyshnyi, Aleksandr (Peer reviewed; Journal article, 2022)Coronavirus disease 2019, or COVID-19, is a major challenge facing scientists worldwide. Alongside the lungs, the system of organs comprising the GI tract is commonly targeted by COVID-19. The dysbiotic modulations in the ... -
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
Buchynskyi, Mykhailo; Kamyshna, Iryna; Oksenych, Valentyn; Zavidniuk, Nataliia; Kamyshnyi, Aleksandr (Journal article; Peer reviewed, 2023) -
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
Petakh, Pavlo; Kamyshna, Iryna; Oksenych, Valentyn; Kainov, Denis; Kamyshnyi, Aleksandr (Peer reviewed; Journal article, 2023)The gut microbiota play a crucial role in maintaining host health and have a significant impact on human health and disease. In this study, we investigated the alpha diversity of gut microbiota in COVID-19 patients and ... -
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience
Kamyshnyi, Aleksandr; Koval, Halyna; Kobevko, Olha; Buchynskyi, Mykhailo; Oksenych, Valentyn; Kaynov, Denis; Lyubomirskaya, Katerina; Kamyshna, Iryna; Potters, Geert; Moshynets, Olena (Peer reviewed; Journal article, 2023)Despite several targeted antiviral drugs against SARS-CoV-2 currently being available, the application of type I interferons (IFNs) still deserves attention as an alternative antiviral strategy. This study aimed to assess ...